Company Presentation

SEITO Biologics’ mission is to develop safer and more efficacious treatments for immune-mediated disorders causing autoimmunity, inflammation and transplant rejection. These serious disorders affect 4% of the population. Current therapies only temporarily relieve the condition and suppress immunity risking infection and cancer. SEITO’s vision it to become a Swiss-based globally active biotechnology leader in developing novel treatments for immune-mediated disorders.